These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21628459)

  • 1. Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis.
    Dasgupta S; Cushman I; Kpetemey M; Casey PJ; Vishwanatha JK
    J Biol Chem; 2011 Jul; 286(29):25935-46. PubMed ID: 21628459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells.
    Dasgupta S; Wasson LM; Rauniyar N; Prokai L; Borejdo J; Vishwanatha JK
    Oncogene; 2009 Aug; 28(32):2860-72. PubMed ID: 19503095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymology and biology of CaaX protein prenylation.
    Fu HW; Casey PJ
    Recent Prog Horm Res; 1999; 54():315-42; discussion 342-3. PubMed ID: 10548882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity.
    Reid TS; Terry KL; Casey PJ; Beese LS
    J Mol Biol; 2004 Oct; 343(2):417-33. PubMed ID: 15451670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Geranylgeranyltransferase Type 1 as a Target in Cancer.
    Ullah N; Mansha M; Casey PJ
    Curr Cancer Drug Targets; 2016; 16(7):563-71. PubMed ID: 26648485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel prenyl and palmitoyl modification at the CaaX motif of Cdc42 that regulates RhoGDI binding.
    Nishimura A; Linder ME
    Mol Cell Biol; 2013 Apr; 33(7):1417-29. PubMed ID: 23358418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-permeable CaaX-peptides affect K-Ras downstream signaling and promote cell death in cancer cells.
    Klimpel A; Stillger K; Wiederstein JL; Krüger M; Neundorf I
    FEBS J; 2021 May; 288(9):2911-2929. PubMed ID: 33112492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of Rab5 N-terminal domain dictate prenylation of C-terminal cysteines.
    Sanford JC; Pan Y; Wessling-Resnick M
    Mol Biol Cell; 1995 Jan; 6(1):71-85. PubMed ID: 7749197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evidence for in vivo cross-specificity of the CaaX-box protein prenyltransferases farnesyltransferase and geranylgeranyltransferase-I in Saccharomyces cerevisiae.
    Trueblood CE; Ohya Y; Rine J
    Mol Cell Biol; 1993 Jul; 13(7):4260-75. PubMed ID: 8321228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal proteolysis of prenylated proteins in trypanosomatids and RNA interference of enzymes required for the post-translational processing pathway of farnesylated proteins.
    Gillespie JR; Yokoyama K; Lu K; Eastman RT; Bollinger JG; Van Voorhis WC; Gelb MH; Buckner FS
    Mol Biochem Parasitol; 2007 Jun; 153(2):115-24. PubMed ID: 17397944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoGDI facilitates geranylgeranyltransferase-I-mediated RhoA prenylation.
    Tnimov Z; Abankwa D; Alexandrov K
    Biochem Biophys Res Commun; 2014 Oct; 452(4):967-73. PubMed ID: 25223799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of protein farnesyltransferase to a geranylgeranyltransferase.
    Terry KL; Casey PJ; Beese LS
    Biochemistry; 2006 Aug; 45(32):9746-55. PubMed ID: 16893176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric regulation of substrate binding and product release in geranylgeranyltransferase type II.
    Thomä NH; Iakovenko A; Kalinin A; Waldmann H; Goody RS; Alexandrov K
    Biochemistry; 2001 Jan; 40(1):268-74. PubMed ID: 11141079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenylation of Rab8 GTPase by type I and type II geranylgeranyl transferases.
    Wilson AL; Erdman RA; Castellano F; Maltese WA
    Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):497-504. PubMed ID: 9677305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase. Creating the perfect farnesyltransferase.
    Caplin BE; Ohya Y; Marshall MS
    J Biol Chem; 1998 Apr; 273(16):9472-9. PubMed ID: 9545274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenylation of oncogenic human PTP(CAAX) protein tyrosine phosphatases.
    Cates CA; Michael RL; Stayrook KR; Harvey KA; Burke YD; Randall SK; Crowell PL; Crowell DN
    Cancer Lett; 1996 Dec; 110(1-2):49-55. PubMed ID: 9018080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resonance assignments of human C35 (C17orf37) protein, a novel tumor biomarker.
    Yang CJ; Chang CF; Huang LY; Chang YY; Shen TL; Hsu CH
    Biomol NMR Assign; 2010 Oct; 4(2):191-3. PubMed ID: 20556552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer.
    Evans EE; Henn AD; Jonason A; Paris MJ; Schiffhauer LM; Borrello MA; Smith ES; Sahasrabudhe DM; Zauderer M
    Mol Cancer Ther; 2006 Nov; 5(11):2919-30. PubMed ID: 17121940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.